References

Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets

for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies.

Viruses 12:254

Allam Z, Jones DS (2020) On the coronavirus (COVID-19) outbreak and the Smart City network:

universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health

monitoring and management. Healthcare 8:46

Aravanis AM, Lee M, Klausner RD (2017) Next-generation sequencing of circulating tumor DNA

for early cancer detection. Cell 168:571–574

Asadzadeh A, Pakkhoo S, Saeidabad MM, Khezri H, Ferdousi R (2020) Information technology in

emergency management of COVID-19 outbreak. Inform Med Unlocked 21:100475

Bherwani H, Anjum S, Kumar S, Gautam S, Gupta A, Kumbhare H et al (2020) Understanding

COVID-19 transmission through Bayesian probabilistic modeling and GIS-based Voronoi

approach: a policy perspective. Environ Dev Sustain 23:5846–5864

Bogoch II, Brady OJ, Kraemer MUG, German M, Creatore MI, Kulkarni MA et al (2016)

Anticipating the international spread of Zika virus from Brazil. Lancet 387:335–336

Cai CZ, Han LY, Chen X, Cao ZW, Chen YZ (2005) Prediction of functional class of the SARS

coronavirus proteins by a statistical learning method. J Proteome Res 4:1855–1862

Chow S-C (2017) Biosimilar clinical development

Christaki E (2015) New technologies in predicting, preventing and controlling emerging infectious

diseases. Virulence 6:558–565

Chu HY, Englund JA, Starita LM, Famulare M, Brandstetter E, Nickerson DA et al (2020) Early

detection of Covid-19 through a citywide pandemic surveillance platform. N Engl J Med 383:

185–187

Cleemput S, Dumon W, Fonseca V, Karim WA, Giovanetti M, Alcantara LC et al (2020) Genome

detective coronavirus typing tool for rapid identification and characterization of novel corona-

virus genomes. Bioinformatics 36:3552–3555

De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW et al (2013) Making

vaccines “on demand”: a potential solution for emerging pathogens and biodefense? Hum

Vaccin Immunother 9:1877–1884

Elfiky AA (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci 248:

117477

Eureka (2019a). The future of drug discovery: AI impacting upon hit ID strategies. https://eureka.

criver.com/the-future-of-drug-discovery-ai-impacting-upon-hit-id-strategies/

Eureka (2019b). Image-based cell profiling. https://eureka.criver.com/image-based-cell-profiling/

Fleming N (2018) How artificial intelligence is changing drug discovery. Nature 557:S55–S57

Francis F, Ishengoma DS, Mmbando BP, Rutta ASM, Malecela MN, Mayala B et al (2017)

Deployment and use of mobile phone technology for real-time reporting of fever cases and

malaria treatment failure in areas of declining malaria transmission in Muheza district North-

Eastern Tanzania. Malar J 16:308

Ghoshal B, Tucker A (2020) Estimating uncertainty and interpretability in deep learning for

coronavirus (COVID-19) detection. arXiv

Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP et al (2017) Long-term

outcomes of imatinib treatment for chronic myeloid Leukemia. N Engl J Med 376:917–927

Hu Z, Ge Q, Li S, Jin L, Xiong M (2020) Artificial intelligence forecasting of covid-19 in China.

arXiv

Kantarjian H, O’Brien S, Jabbour E, Garcia-Manero G, Quintas-Cardama A, Shan J et al (2012)

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a

single-institution historical experience. Blood 119:1981–1987

Kim J, Zhang J, Cha Y, Kolitz S, Funt J, Chong RE et al (2020) Advanced bioinformatics rapidly

identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19). J Transl

Med 18:257

1

Emerging Technologies: Gateway to Understand Molecular Insight of. . .

13